260 research outputs found

    Characterization of the Hemagglutinin Cleaving Transmembrane Serine Proteases Matriptase and TMPRSS2

    Get PDF
    Influenza is one of the commonest infectious diseases affecting millions of people every year including 290,000 – 650,000 heavy casualties. Influenza viruses undergo constant genetic changes and every 10 – 50 years new influenza virus strains emerge that potentially cause a severe pandemic. In this modern interconnected world, experts believe the next influenza pandemic will be a “devastating global health event with far-reaching consequences” [1]. Novel effective anti-influenza drugs are in need. One strategy of influenza research is to focus on host-specific proteases that are essential for virus activation and spread. Trypsin-like serine proteases are crucial for influenza activation by mediating the cleavage of the viral surface glycoprotein HA and hence promoting the fusion potential of the virus. Therefore, their inhibition provides a promising therapeutic approach. The present work focused on the characterization of two relevant HA cleaving type-II transmembrane serine proteases matriptase and TMPRSS2. Chapter 3 and chapter 4 of this thesis engaged with the recombinant production of matriptase (chapter 3) in order to obtain a pure functional enzyme of high quality for a SAR study with novel monobasic (hence potentially bioavailable) matriptase inhibitors of the 3-amidinophenylalanine type (chapter 4). Adequate amounts of high-quality matriptase enzymes were isolated using a new expression system and in total 5 matriptase crystals were available at the end of this thesis for structural analysis. The matriptase inhibitor design in this thesis focused on matriptase-affine compounds with a fair selectivity profile against the blood coagulation enzymes thrombin and fXa. In total, 18 new monobasic and potentially bioavailable, as well as four new dibasic compounds of the 3-amidinophenylalanine types were tested. Based on the last published crystal structure of this inhibitor type in complex with matriptase from 2006 (PDB code 2GV6) docking was used as a structure-based virtual screening method for lead optimization of the compounds N-terminus. Selected compounds were suggested to interact with the carbonyl side chain of Gln175 of matriptase to achieve a higher affinity of matriptase compared to fXa. The 4-tert-butylureido-piperidine could be identified as suitable C-terminus in combination with 3-fluoro-4-hydroxymethyl biphenylsulphonyl N-terminally in order to obtain excellent selectivity over thrombin. The binding mode of this compound (compound 55) was crystallographically determined in complex with matriptase as well as trypsin. Trypsin proved as a suitable alternative to matriptase for detailed binding mode analysis of the compounds N-terminus. However, different preferences were detected for the C-terminus. Dibasic compounds showed higher matriptase affinity and selectivity in comparison with the monobasic analogues. However, the tested monobasic compounds were still decent matriptase inhibitors that are additionally suitable for cell culture and animal studies in their benzamidine prodrug forms, which are well established from related inhibitors of thrombin. In addition, selected monobasic as well as dibasic compounds demonstrated strong suppression of the replication of certain H9N2 influenza viruses in a matriptase-expressing MDCK II cell model. These matriptase inhibitors could be potential lead structures for the development of new drugs against H9 strains for influenza. TMPRSS2 is widely discussed for its role in influenza activation. With a TMPRSS2 dependancy of HA-activation of certain subtypes, the characterization of this protease is an important prerequisite for being available as a target for influenza drug design. However, only little is known about the physiological function of TMPRSS2 and no experimental structure data are available at the moment to enable a structure-based drug development. Therefore, chapter 5 of this thesis focused on the characterization of TMPRSS2 in order to develop a strategy for the isolation of proteolytically active TMPRSS2 from cell culture. Even though, no functional TMPRSS2 could be recovered at the end of this work some new structural characteristics of TMPRSS2 were identified as crucial for functionality insight the cell. In general, TMPRSS2 without the cytosolic part, the transmembrane domain and the LDLRA domain is able to undergo autocatalytically activation if an artificial signal peptide was added N-terminal to enable entry into the endoplasmic reticulum. The presence of the cysteine-rich SRCR domain and the presence of the disulfide chain that connects the SPD and the stem region after activation cleavage have been identified as crucial for activity. N-terminal truncation of TMPRSS2 did not result in obvious dislocation within the cell: as the full-length positive control truncated TMPRSS2 was exclusively found in cell compartments surrounding the nucleus in immunofluorescence experiments. However, a reduced proteolytic cleavage activity towards H3-HA in co-expression experiments has been observed and might be a result of dislocation, since truncated TMPRSS2 is not bound to the biomembrane anymore. In addition, TMPRSS2 has been identified as a potential substrate of matriptase in vitro, which suggests possible participation in several zymogen cascades

    Insect expression systems : improving intracellular and heterologous gene expression

    Get PDF
    Expression systems (ES) in a wide variety of biological systems are used to provide foreign protein. Protein production in mammalian cells is a labour-intensive and expensive process and insect cells have been used as cheaper alternatives. Insect ES are based on two types of vector; viral- and plasmid-based. The baculovirus ES (BES) offers high-level transient production of intracellular proteins. Yields of secreted and membrane-targeted proteins have until recently been relatively low, however, the development of a novel vector, lacking chitinase, has overcome these limitations. Plasmid-based vectors can be used for transient and stable expression in insect cells but most utilise the relatively weak Autographa californica multiple nucleopolyhedrovirus (AcMNPV) immediate early-1 (ie-1) promoter, producing low-levels of intracellular recombinant protein. More recent vectors have used stronger promoters, however, compared with mammalian stable ES these are limited in use and most notable is the lack of an efficient inducible ES in insect cells. The work in this thesis describes methods, with which intracellular levels of foreign protein may be increased, while also developing the grounding work for the development of a fully functional insect tetracycline regulatory system. To improve stable and regulated expression of heterologous genes in insect cells, work was undertaken to compare and characterise the transcriptional activity of a range of promoters successfully used in insect and mammalian systems. Of the promoters tested, Orgyia pseudotsugata MNPV (Op) ie-2 and Bombyx morl actin 3 (BmA3+E) were found to be transcriptionally stronger than AcMNPV ie-1. Drosophila melanogaster metallothionein and actin 5.1 did not produce any detectable activity, and the Cytomegalovirus (CMV) ie promoter, although active, was weaker than AcMNPV ;e-1. Attempts to develop a new inducible ES for use in stable cell lines was based on modifying a mammalian tetracyclineinducible ES. The original CMVie promoters were replaced by the Bm A3+E and Op ie-2 promoters that had been shown to be optimal in insect cells. The Bm A3+E promoter was successfully used to express the tetracycline transcriptional activator protein. Studies also demonstrated that the constitutive transcriptional activity of Op ie-2, used to drive expression of a reporter gene, was successfully suppressed in normal medium. However, in the presence of the inducer, doxycycline, transcriptional activity of Op ie-2 was not activated. Work to elucidate why Op ie-2 remain repressed in the presence of the inducer, indicated that other, uncharacterised vector sequences may have interfered with the activation process. To determine whether stable insect cell lines could be used as an effective alternative to the BES for producing large quantities of intracellular foreign proteins, protein production from stable cell lines, using the Bm A3+E promoter, were compared to the BES using a range of reporter proteins. It was concluded that with vectors currently available, stable cell lines would not normally provide an effective alternative to the BES. However, a stable insect cell line expressing Discosoma red was used to develop methods for scaling-up continuous cultivation of cells in an open fermenter system. This stable cell line was successfully maintained without contamination or total loss of cell viability for 4 weeks. Improving intracellular expression of foreign genes using the BES, initially focused on investigating whether a baculovirus vector (BV) lacking chitinase could produce larger yields than normal BV. It was concluded that recombinant BV lackingchitinase could be used to improve intracellular levels of foreign protein, but demonstrated the importance of optimiSing production conditions for each recombinant protein (e.g., vector and cell line). Intracellular levels of foreign protein were further improved from the BES using different culturing methodologies (fermentation and shaker flask) and concluded that fermenters produced optimal conditions for intracellular protein production, probably due to maintaining a constant level of dissolved oxygen concentration during virus infection

    Viral Gene Therapy

    Get PDF
    The development of technologies that allow targeting of specific cells has progressed substantially in recent years for several types of vectors, particularly viral vectors, which have been used in 70% of gene therapy clinical trials. Particular viruses have been selected as gene delivery vehicles because of their capacities to carry foreign genes and their ability to efficiently deliver these genes associated with efficient gene expression. This book is designed to present the most recent advances in viral gene therap

    Oncogene and Cancer

    Get PDF
    This book describes a course of cancer growth starting from normal cells to cancerous form and the genomic instability, the cancer treatment as well as its prevention in form of the invention of a vaccine. Some diseases are also discussed in detail, such as breast cancer, leucaemia, cervical cancer, and glioma. Understanding cancer through its molecular mechanism is needed to reduce the cancer incidence. How to treat cancer more effectively and the problems like drug resistance and metastasis are very clearly illustrated in this publication as well as some research result that could be used to treat the cancer patients in the very near future. The book was divided into six main sections: 1. HER2 Carcinogenesis: Etiology, Treatment and Prevention; 2. DNA Repair Mechanism and Cancer; 3. New Approach to Cancer Mechanism; 4. New Role of Oncogenes and Tumor Suppressor Genes; 5. Non Coding RNA and Micro RNA in Tumorigenesis; 6. Oncogenes for Transcription Factor
    • …
    corecore